George J. Morrow
American business executive.1
Companies
- Neurocrine BiosciencesBoard member Oct 1, 2015 to now8
- Align TechnologyBoard member Feb 23, 2006 to now9
- Fresh Tracks Therapeutics, Inc.Board member Oct 17, 2012 to May 24, 201810
- Otonomy (United States)Board member Apr 30, 2015 to Jul 14, 201711
- SafewayBoard member May 15, 2013 to Feb 2, 201512
- AmgenExe VP, Global Commercial Ops Apr 4, 2006 to Apr 30, 201013
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Neurocrine Biosciences NBIX10,386 shares14$1.4M at $137.36May 21, 2026
Align Technology ALGN8,309 shares15$1.2M at $149.46May 22, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 21, 2026Exercised options 3,318 shares of Neurocrine Biosciences14
- May 20, 2026Exercised options 1,745 shares of Align Technology15
- Nov 25, 2025Sold 15,000 shares at $143.37 of Neurocrine Biosciences16
- Nov 25, 2025Exercised options 15,000 shares at $47.89 of Neurocrine Biosciences16
- May 22, 2025Exercised options 2,869 shares of Neurocrine Biosciences17
- May 21, 2025Exercised options 1,148 shares of Align Technology18
- May 17, 2024Exercised options 4,199 shares of Neurocrine Biosciences19
- May 17, 2024Exercised options 1,029 shares of Align Technology20
- Mar 14, 2024Sold 20,000 shares at $139.41 of Neurocrine Biosciences21
- Mar 14, 2024Exercised options 20,000 shares at $39.79 of Neurocrine Biosciences21
- Mar 14, 2024Sold 20,000 shares at $139.42 of Neurocrine Biosciences21
- Mar 14, 2024Exercised options 20,000 shares at $39.79 of Neurocrine Biosciences21
- May 30, 2023Gift 10,000 shares of Align Technology22
- May 17, 2023Exercised options 1,114 shares of Align Technology23
- May 18, 2022Exercised options 524 shares of Align Technology24
Early life and education
Career
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataGeorge J. Morrow on Wikidata
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARNeurocrine Biosciences, Board member
- 9Wikidata and SEC EDGARAlign Technology, Board member
- 10
- 11
- 12SEC EDGARSafeway, Board member
- 13SEC EDGARAmgen, Exe VP, Global Commercial Ops
- 14
- 15
- 16SEC EDGARForm 4 filed Nov 26, 2025
- 17SEC EDGARForm 4 filed May 22, 2025
- 18SEC EDGARForm 4 filed May 22, 2025
- 19SEC EDGARForm 4 filed May 21, 2024
- 20SEC EDGARForm 4 filed May 21, 2024
- 21SEC EDGARForm 4 filed Mar 15, 2024
- 22SEC EDGARForm 4 filed May 31, 2023
- 23SEC EDGARForm 4 filed May 19, 2023
- 24SEC EDGARForm 4 filed May 19, 2022